Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Allergy, Asthma & Clinical Immunology
Published in: Allergy, Asthma & Clinical Immunology 1/2018

Open Access 01-12-2018 | Research

Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation

Authors: Gabor Tajti, Csaba Papp, Laszlo Kardos, Sandor Keki, Krisztian Pak, Magdolna Emma Szilasi, Rudolf Gesztelyi, Angela Mikaczo, Andrea Fodor, Maria Szilasi, Judit Zsuga

Published in: Allergy, Asthma & Clinical Immunology | Issue 1/2018

Login to get access

Abstract

Background

Contribution of nitric-oxide (NO) pathway to the pathogenesis of bronchial asthma (asthma) is ambiguous as NO may confer both protective and detrimental effects depending on the NO synthase (NOS) isoforms, tissue compartments and underlying pathological conditions (e.g. systemic inflammation). Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor and uncoupler of NOS with distinct selectivity for NOS isoforms. In a cross-sectional study, we assessed whether ADMA is an independent predictor of airway resistance (Raw) in therapy-controlled asthma.

Methods

154 therapy-controlled asthma patients were recruited. ADMA, symmetric dimethylarginine and arginine were quantitated by HPLC with fluorescent detection. Pulmonary function test was done using whole-body plethysmography, quality of life via St. George’s Respiratory questionnaire (SGRQ). Multiple linear regression was used to identify independent determinants of Raw. The final model was stratified based on therapy control.

Results

Evidence for systemic inflammation indicated by CRP and procalcitonin was lacking in our sample. Log Raw showed significant positive correlation with log ADMA in the whole data set and well-controlled but not in the not well-controlled stratum (Spearman correlation coefficients: 0.27, p < 0.001; 0.30, p < 0.001; 0.12, p = 0.51 respectively). This relationship remained significant after adjusting for confounders by multiple linear regression (β = 0.22, CI 0.054, 0.383 p = 0.01). FEF 25–75% % predicted and SGRQ Total score showed significant negative while SGRQ Activity score showed significant positive correlation with Raw in the final model.

Conclusions

Positive correlation between Raw and ADMA in the absence of systemic inflammation implies that higher ADMA has detrimental effect on NO homeostasis and can contribute to a poor outcome in asthma.
Literature
1.
To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:1.CrossRef
2.
3.
4.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–65.CrossRefPubMed
5.
Zsuga J, Torok J, Magyar MT, Valikovics A, Gesztelyi R, Keki S, Csiba L, Zsuga M, Bereczki D. Serum asymmetric dimethylarginine negatively correlates with intima-media thickness in early-onset atherosclerosis. Cerebrovasc Dis. 2007;23:388–94.CrossRefPubMed
6.
Zsuga J, Török J, Magyar MT, Valikovics A, Gesztelyi R, Lenkei Á, Csiba L, Kéki S, Zsuga M, Bereczki D. Dimethylarginines at the crossroad of insulin resistance and atherosclerosis. Metab Clin Exp. 2007;56:394–9.CrossRefPubMed
7.
Dupont LL, Glynos C, Bracke KR, Brouckaert P, Brusselle GG. Role of the nitric oxide–soluble guanylyl cyclase pathway in obstructive airway diseases. Pulm Pharmacol Ther. 2014;29:1–6.CrossRefPubMed
8.
Ricciardolo FL, Nijkamp FP, Folkerts G. Nitric oxide synthase (NOS) as therapeutic target for asthma and chronic obstructive pulmonary disease. Curr Drug Targets. 2006;7:721–35.CrossRefPubMed
9.
Fischer A, Hoffmann B. Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man. Correlation with neuropeptides. Am J Respir Crit Care Med. 1996;154:209–16.CrossRefPubMed
10.
Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC. Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci U S A. 1995;92:7809–13.CrossRefPubMedPubMedCentral
11.
Wells SM, Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol. 2007;36:520–8.CrossRefPubMed
12.
Haddad E, Liu SF, Salmon M, Robichaud A, Barnes PJ, Chung KF. Expression of inducible nitric oxide synthase mRNA in Brown Norway rats exposed to ozone: effect of dexamethasone. Eur J Pharmacol Environ Toxicol Pharm. 1995;293:287–90.CrossRef
13.
Prado CM, Martins MA, Tibério IF. Nitric oxide in asthma physiopathology. ISRN allergy. 2011;2011:832560.
14.
Saleh D, Ernst P, Lim S, Barnes PJ, Giaid A. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J. 1998;12:929–37.PubMed
15.
Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers. CHEST J. 2007;132:581–8.CrossRef
16.
Klein E, Weigel J, Buford MC, Holian A, Wells SM. Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol. 2010;299:L816–25.CrossRefPubMedPubMedCentral
17.
Cardounel AJ, Xia Y, Zweier JL. Endogenous methylarginines modulate superoxide as well as nitric oxide generation from neuronal nitric-oxide synthase: differences in the effects of monomethyl- and dimethylarginines in the presence and absence of tetrahydrobiopterin. J Biol Chem. 2005;280:7540–9.CrossRefPubMed
18.
Druhan LJ, Forbes SP, Pope AJ, Chen C, Zweier JL, Cardounel AJ. Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry (N Y). 2008;47:7256–63.CrossRef
19.
Ahmad T, Mabalirajan U, Ghosh B, Agrawal A. Altered asymmetric dimethyl arginine metabolism in allergically inflamed mouse lungs. Am J Respir Cell Mol Biol. 2010;42:3–8.CrossRefPubMed
20.
Kinker KG, Gibson AM, Bass SA, Day BP, Deng J, Medvedovic M, Figueroa JAL, Hershey GKK, Chen W. Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma. PLoS ONE. 2014;9:e85148.CrossRefPubMedPubMedCentral
21.
Calabrese C, Carpagnano GE, Patella V, Vatrella A, Santus P. Asymmetric dimethylarginine (ADMA): will be or will not be a new revolutionary biomarker of bronchial asthma? Minerva Med. 2015;106(5(suppl. 1)):9–11.PubMed
22.
Holguin F, Comhair SA, Hazen SL, Powers RW, Khatri SS, Bleecker ER, Busse WW, Calhoun WJ, Castro M, Fitzpatrick AM. An association between l-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med. 2013;187:153–9.CrossRefPubMedPubMedCentral
23.
Riccioni G, Bucciarelli V, Verini M, Consilvio N, Gallina S, Martini F, Aceto A, Scotti L, Bucciarelli T. ADMA, SDMA, l-Arginine and nitric oxide in allergic pediatric bronchial asthma. J Biol Regul Homeost Agents. 2012;26:561.PubMed
24.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. Strobe Initiative. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Prev Med. 2007;45:247–51.CrossRef
25.
Boulet LP, FitzGerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, Bateman ED. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J. 2012;39:1220–9.CrossRefPubMed
26.
Collage of Pulmonologists. Guideline of the Ministry of Health on the diagnosis, therapy and chronic care of bronchial asthma. Egészségügyi Közlöny. 2011;61:275.
27.
WHO. WHO collaborating centre for drug statistics methodology. ATC/DDD index. Geneva: WHO; 2016.
28.
Topalovic M, Derom E, Osadnik CR, Troosters T, Decramer M, Janssens W. Airways resistance and specific conductance for the diagnosis of obstructive airways diseases. Respir Res. 2015;16:1.CrossRef
29.
Meguro M, Barley EA, Spencer S, Jones PW. Development and validation of an improved, COPD-specific version of the St. George Respiratory questionnaire. CHEST J. 2007;132:456–63.CrossRef
30.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J. ATS/ERS task force. Standardisation of spirometry. Eur Respir J. 2005;26:319–38.CrossRefPubMed
31.
Wanger J, Clausen J, Coates A, Pedersen O, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, Van Der Grinten C. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26:511.CrossRefPubMed
32.
Stocks J, Godfrey S, Beardsmore C, Bar-Yishay E, Castile R. ERS/ATS task force on standards for infant respiratory function testing. european respiratory society/American Thoracic Society. Plethysmographic measurements of lung volume and airway resistance. ERS/ATS task force on standards for infant respiratory function testing. European Respiratory Society/American Thoracic Society. Eur Respir J. 2001;17:302–12.CrossRefPubMed
33.
Jones PW, Quirk F, Baveystock C. The St George’s respiratory questionnaire. Respir Med. 1991;85:25–31.CrossRefPubMed
34.
Jones PW. St. George’s respiratory questionnaire: MCID. COPD J Chronic Obstructive Pulmonary Disease. 2005;2:75–9.CrossRef
35.
Quanjer PH. Standardized lung function testing: report working party” Standardization of Lung Function Tests”, European Community for coal and steel. Luxembourg: Pergamon press; 1983.
36.
Contoli M, Bousquet J, Fabbri L, Magnussen H, Rabe K, Siafakas N, Hamid Q, Kraft M. The small airways and distal lung compartment in asthma and COPD: a time for reappraisal. Allergy. 2010;65:141–51.CrossRefPubMed
37.
Contoli M, Santus P, Papi A. Small airway disease in asthma: pathophysiological and diagnostic considerations. Curr Opin Pulm Med. 2015;21:68–73.CrossRefPubMed
38.
Wells SM, Holian A. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol. 2007;36:520–8.CrossRefPubMed
39.
Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res. 2003;92:226–33.CrossRefPubMed
40.
Tsikas D, Sandmann J, Savva A, Lueßen P, Böger RH, Gutzki F, Mayer B, Frölich JC. Assessment of nitric oxide synthase activity in vitro and in vivo by gas chromatography–mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000;742:143–53.CrossRefPubMed
41.
Carraro S, Giordano G, Piacentini G, Kantar A, Moser S, Cesca L, Berardi M, Di Gangi IM, Baraldi E. Asymmetric dimethylarginine in exhaled breath condensate and serum of children with asthma. CHEST J. 2013;144:405–10.CrossRef
42.
Lau EM, Morgan PE, Belousova EG, Toelle BG, Ayer JG, Celermajer DS, Marks GB. Asymmetric dimethylarginine and asthma: results from the Childhood Asthma Prevention Study. Eur Respir J. 2013;41:1234–7.CrossRefPubMed
43.
Usmani OS. Small-airway disease in asthma: pharmacological considerations. Curr Opin Pulm Med. 2015;21:55–67.CrossRefPubMed
44.
Baraldo S, Saetta M, Cosio MG. Pathophysiology of the small airways. Semin Respir Critical Care Med. 2003;24:465–72.CrossRef
45.
Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol. 1985;1992(72):1016–23.
46.
Barley E, Jones P. A comparison of global questions versus health status questionnaires as measures of the severity and impact of asthma. Eur Respir J. 1999;14:591–6.CrossRefPubMed
47.
Koch B, Friedrich N, Voelzke H, Joerres RA, Felix SB, Ewert R, Schaeper C, Glaeser S. Static lung volumes and airway resistance reference values in healthy adults. Respirology. 2013;18:170–8.CrossRefPubMed
Metadata
Title
Positive correlation of airway resistance and serum asymmetric dimethylarginine (ADMA) in bronchial asthma patients lacking evidence for systemic inflammation
Authors
Gabor Tajti
Csaba Papp
Laszlo Kardos
Sandor Keki
Krisztian Pak
Magdolna Emma Szilasi
Rudolf Gesztelyi
Angela Mikaczo
Andrea Fodor
Maria Szilasi
Judit Zsuga
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Allergy, Asthma & Clinical Immunology / Issue 1/2018
Electronic ISSN: 1710-1492
DOI
https://doi.org/10.1186/s13223-017-0226-5

Other articles of this Issue 1/2018

Allergy, Asthma & Clinical Immunology 1/2018 Go to the issue

Short Report

The course of asthma during pregnancy in a recent, multicase–control study on respiratory health

Review

An update on molecular cat allergens: Fel d 1 and what else? Chapter 1: Fel d 1, the major cat allergen

Research

Aetiology of anaphylaxis in patients referred to an immunology clinic in Colombo, Sri Lanka

Research

Effects of nasal dilator strips on subjective measures of sleep in subjects with chronic nocturnal nasal congestion: a randomized, placebo-controlled trial

Case report

New onset colitis in an adult patient with chronic granulomatous disease treated with hematopoietic stem cell transplantation: a diagnostic dilemma

Research

Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma